Annex Publishers

This retrospective chart review aimed to assess the efficacy of compounded semaglutide, the active ingredient of an FDA-approved weight loss drug for patients with obesity, for weight loss in otherwise healthy, regular, and overweight people (BMI < 29.9). Additionally, a novel method to declare the ideal or target weight, which bridges the difference in body composition, bone structure and sex is proposed. Achieving a target weight is also proposed to measure the success of the elective weight loss (EWL™) program.

Neural implants have revolutionized neurology and neuroscience by offering novel therapeutic avenues for neurological dis orders and functional restoration. However, their efficacy is often compromised by neuroinflammation, a complex and mul tifaceted response that adversely affects device performance and longevity. Understanding the mechanisms underlying neu roinflammation and its impact on neural implants are critical for developing strategies to mitigate these effects. Advances in biocompatible biomaterials and implant technologies, informed by neuroinflammatory research, hold promise for reducing immune reactivity and enhancing device functionality. Machine learning and novel signal processing methods are two of the most important recent advancements in software technology that have contributed to this quick progress. Application development in neuroscience is increasing as artificial intelligence (AI) systems get more sophisticated, effective, and quick. AI has the potential to enhance neural implant signal processing methods, such as the brain's interpretation of electrical im pulses. The quality of life and long-term outcomes for people with neurological disorders may improve as a result of these important advancements in neurotechnology

The evolution of information technology has brought enormous changes in people’s lives. These changes have led to enhance the quality of life of individuals, but it has its own loopholes. This can be witnessed in terms of the origin of cyber-crimes in the society. Computer and internet-oriented crimes are referred to as cyber-crimes

Subclinical hypothyroidism (SCH) is a biochemical disorder characterized by elevated serum thyroid-stimulat ing hormone (TSH) with normal free thyroxine (FT4) levels, in the absence of clinical symptoms. The prevalence of SCH is approximately 1.7% in the pediatric population. Several prognostic factors influence the progression to overt hypothy roidism (OH), which requires lifelong therapy and follow-up. These factors include goiter, elevated TSH levels, positive thy roid antibodies, and obesity. Obesity may also contribute to the development of SCH, making weight loss and monitoring of TSH levels important.The study aimed to assess the role of the change in BMI classification as a prognostic factor for the spontaneous healing of SCH

This retrospective chart review aimed to assess the efficacy of compounded semaglutide, the active ingredient of an FDA-approved weight loss drug for patients with obesity, for weight loss in otherwise healthy, regular, and overweight people (BMI < 29.9). Additionally, a novel method to declare the ideal or target weight, which bridges the difference in body composition, bone structure and sex is proposed. Achieving a target weight is also proposed to measure the success of the elective weight loss (EWL™) program.

Neural implants have revolutionized neurology and neuroscience by offering novel therapeutic avenues for neurological dis orders and functional restoration. However, their efficacy is often compromised by neuroinflammation, a complex and mul tifaceted response that adversely affects device performance and longevity. Understanding the mechanisms underlying neu roinflammation and its impact on neural implants are critical for developing strategies to mitigate these effects. Advances in biocompatible biomaterials and implant technologies, informed by neuroinflammatory research, hold promise for reducing immune reactivity and enhancing device functionality. Machine learning and novel signal processing methods are two of the most important recent advancements in software technology that have contributed to this quick progress. Application development in neuroscience is increasing as artificial intelligence (AI) systems get more sophisticated, effective, and quick. AI has the potential to enhance neural implant signal processing methods, such as the brain's interpretation of electrical im pulses. The quality of life and long-term outcomes for people with neurological disorders may improve as a result of these important advancements in neurotechnology

The evolution of information technology has brought enormous changes in people’s lives. These changes have led to enhance the quality of life of individuals, but it has its own loopholes. This can be witnessed in terms of the origin of cyber-crimes in the society. Computer and internet-oriented crimes are referred to as cyber-crimes

Subclinical hypothyroidism (SCH) is a biochemical disorder characterized by elevated serum thyroid-stimulat ing hormone (TSH) with normal free thyroxine (FT4) levels, in the absence of clinical symptoms. The prevalence of SCH is approximately 1.7% in the pediatric population. Several prognostic factors influence the progression to overt hypothy roidism (OH), which requires lifelong therapy and follow-up. These factors include goiter, elevated TSH levels, positive thy roid antibodies, and obesity. Obesity may also contribute to the development of SCH, making weight loss and monitoring of TSH levels important.The study aimed to assess the role of the change in BMI classification as a prognostic factor for the spontaneous healing of SCH